A combination of THC, CBD and Cobalamin (in a ratio of about 63%, 27% and 10%, respectively) is used with a topical carrier such as Shea butter cream to relieve pain. The THC and CBD mixture is extracted from a Cannabis Indica dominant strain using high pressure and carbon dioxide (CO.sub.2) as a solvent and comprises: Tetrahydrocannabinol "THC" (9-Tetrahydrocannabinol (delta-9 THC), 8-Tetrahydrocannabinol (Delta-8 THC) and 9-THC Acid), Cannabidiol "CBD", Cannabinol "CBN", Cannabichromene ("CBC"), Cannabigerol ("CBG"), terpenoids and flavonoids. The Shea butter is an extract from the Shea nut from the Shea tree (Vitellaria paradoxa).

India Globalization Capital, Inc.

Cannabinoid composition for treating pain

The present invention is a process for producing various types of cannabis extract from harvested cannabis. A quantity of harvested cannabis, which typically includes the inflorescence, floral leaves, and small stems of a flowering cannabis plants, is pre-frozen. The harvested cannabis is first subjected to cryogenic grinding to produce pulverized cannabis. The pulverized cannabis is then subjected to alcohol extraction to produce an initial cannabis extract, which can be subjected to one of several forms of further processing according to the desired chemical profile of the final product. The initial cannabis extract may then be subjected to chemical processing that promote the conversion of THCA to .DELTA.9 THC; the conversion of THCVA to THCV; the conversion of THCA to cannabinol ("CBN"); or the conversion of THCA to .DELTA.8-THC.

Jenny's Rose, LLC

Producing cannabis extracts via selective decarboxylation

Preparation of cannabinoid formulations containing: .DELTA.9-tetrahydrocannabinol (.DELTA.9-THC), .DELTA.8-tetrahydrocannabinol (.DELTA.8-THC), .DELTA.9-tetrahydrocannabinolic acid (THCa), cannabidiol (CBD), cannabidiolic acid (CBDa), cannabigerol (CBG), cannabichromene (CBC) and cannabinol (CBN), either alone or in combinations henceforth known as cannabis, have been created using an emulsification process to encapsulate cannabinoids. The aqueous-based method involves micellular encapsulation of cannabinoids, a method that has been used to increase the bioavailability of poorly permeable, lipophilic drugs. The present invention demonstrates the viability of transdermal delivery with gels and patches for consistent and sustained cannabinoid dosing.

Nutrae, LLC

NUTRAE, LLC

Encapsulated cannabinoid formulations for transdermal delivery

Preparation of cannabinoid formulations containing: .DELTA.9-tetrahydrocannabinol (.DELTA.9-THC), .DELTA.8-tetrahydrocannabinol (.DELTA.8-THC), .DELTA.9-tetrahydrocannabinolic acid (THCa), cannabidiol (CBD), cannabidiolic acid (CBDa), cannabigerol (CBG), cannabichromene (CBC) and cannabinol (CBN), either alone or in combinations henceforth known as Cannabis, have been created using an emulsification process to encapsulate cannabinoids. The aqueous-based method involves micellular encapsulation of cannabinoids, a method that has been used to increase the bioavailability of poorly permeable, lipophilic drugs. These preparations demonstrates the viability of sublingual, buccal, or oral delivery using an aqueous-based encapsulation method, including as a beverage or drink.

delta 8 thc/kanep

Cannabinoid composition for treating pain

Producing cannabis extracts via selective decarboxylation

Encapsulated cannabinoid formulations for transdermal delivery

Encapsulated cannabinoid formulations for oral delivery

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus